Marie-Émilie Dourthe

Determinants of CD19-positive vs CD19-negative relapse after tisagenlecleucel for B-cell acute lymphoblastic leukemia

Marie-Émilie Dourthe, Florence Rabian, Karima Yakouben et al. · Leukemia · 2021 · 145 citations

Hematological Malignancy, Lymphoid Neoplasia, Transplantation +10

CD19 CAR T-cells for pediatric relapsed acute lymphoblastic leukemia with active CNS involvement: a retrospective international study

Elad Jacoby, Sara Ghorashian, Britta Vormoor et al. · Leukemia · 2022 · 61 citations

Hematological Malignancy, Neuro-oncology, Cell Therapy +11

Renal outcome in children with antenatal diagnosis of severe CAKUT

Julien Hogan, Marie-Émilie Dourthe, Éléonore Blondiaux et al. · Pediatric Nephrology · 2011 · 40 citations

Urology, Renal Outcome, Medicine +4

PRC2 loss of function confers a targetable vulnerability to BET proteins in T-ALL

Guillaume P. Andrieu, Milena Kohn, Mathieu Simonin et al. · Blood · 2021 · 36 citations · Full text

Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins

Thomas Steimlé, Marie-Émilie Dourthe, Marion Alcantara et al. · Blood Cancer Journal · 2022 · 33 citations · Full text